O	O	0	14	Glucocorticoid	Glucocorticoid	B-NP	NN	O	4	NMOD	O
O	O	14	15	-	-	B-NP	HYPH	O	1	P	O
O	O	15	22	induced	induce	I-NP	VBN	O	4	NMOD	O
O	O	23	32	apoptosis	apoptosis	I-NP	NN	O	0	ROOT	O
O	O	33	35	of	of	B-PP	IN	O	4	NMOD	O
O	O	36	44	lymphoid	lymphoid	B-NP	JJ	B-cell_type	7	NMOD	B-cell_type
O	O	45	50	cells	cell	I-NP	NNS	I-cell_type	5	PMOD	I-cell_type
O	O	50	51	.	.	O	.	O	4	P	O

O	O	53	56	The	The	B-NP	DT	O	2	NMOD	O
O	O	57	66	induction	induction	I-NP	NN	O	11	SUB	O
O	O	67	69	of	of	B-PP	IN	O	2	NMOD	O
O	O	70	74	cell	cell	B-NP	NN	O	5	NMOD	O
O	O	75	80	death	death	I-NP	NN	O	3	PMOD	O
O	O	81	83	in	in	B-PP	IN	O	5	NMOD	O
O	O	84	92	lymphoid	lymphoid	B-NP	JJ	B-cell_type	8	NMOD	B-cell_type
O	O	93	98	cells	cell	I-NP	NNS	I-cell_type	6	PMOD	I-cell_type
O	O	99	101	by	by	B-PP	IN	O	2	NMOD	O
O	O	102	117	glucocorticoids	glucocorticoid	B-NP	NNS	O	9	PMOD	O
O	O	118	120	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	121	124	one	one	B-NP	CD	O	11	PRD	O
O	O	125	127	of	of	B-PP	IN	O	12	NMOD	O
O	O	128	131	the	the	B-NP	DT	O	20	NMOD	O
O	O	132	140	earliest	early	I-NP	JJS	O	20	NMOD	O
O	O	141	144	and	and	I-NP	CC	O	20	NMOD	O
O	O	145	149	most	most	I-NP	RBS	O	18	AMOD	O
O	O	150	160	thoroughly	thoroughly	I-NP	RB	O	20	NMOD	O
O	O	161	168	studied	study	I-NP	VBN	O	20	NMOD	O
O	O	169	175	models	model	I-NP	NNS	O	13	PMOD	O
O	O	176	178	of	of	B-PP	IN	O	20	NMOD	O
O	O	179	188	apoptosis	apoptosis	B-NP	NN	O	21	PMOD	O
O	O	188	189	.	.	O	.	O	11	P	O

O	O	190	198	Although	Although	B-SBAR	IN	O	18	VMOD	O
O	O	199	202	the	the	B-NP	DT	O	4	NMOD	O
O	O	203	208	exact	exact	I-NP	JJ	O	4	NMOD	O
O	O	209	218	mechanism	mechanism	I-NP	NN	O	11	SUB	O
O	O	219	221	by	by	B-PP	IN	O	4	NMOD	O
O	O	222	227	which	which	B-NP	WDT	O	5	PMOD	O
O	O	228	237	apoptosis	apoptosis	B-NP	NN	O	8	SUB	O
O	O	238	244	occurs	occur	B-VP	VBZ	O	5	SBAR	O
O	O	245	247	in	in	B-PP	IN	O	8	VMOD	O
O	O	248	259	lymphocytes	lymphocyte	B-NP	NNS	B-cell_type	9	PMOD	B-cell_type
O	O	260	262	is	be	B-VP	VBZ	O	1	SBAR	O
O	O	263	270	unknown	unknown	B-NP	JJ	O	11	PRD	O
O	O	271	275	many	many	I-NP	JJ	O	18	SUB	O
O	O	276	287	biochemical	biochemical	I-NP	JJ	O	13	NMOD	O
O	O	288	291	and	and	I-NP	CC	O	13	NMOD	O
O	O	292	301	molecular	molecular	I-NP	JJ	O	13	NMOD	O
O	O	302	309	changes	change	I-NP	NNS	O	13	NMOD	O
O	O	310	314	have	have	B-VP	VBP	O	0	ROOT	O
O	O	315	319	been	be	I-VP	VBN	O	18	VC	O
O	O	320	325	shown	show	I-VP	VBN	O	19	VC	O
O	O	326	328	to	to	I-VP	TO	O	22	VMOD	O
O	O	329	334	occur	occur	I-VP	VB	O	20	VMOD	O
O	O	335	337	in	in	B-PP	IN	O	22	VMOD	O
O	O	338	343	these	these	B-NP	DT	O	25	NMOD	O
O	O	344	349	cells	cell	I-NP	NNS	O	23	PMOD	O
O	O	350	352	in	in	B-PP	IN	O	22	VMOD	O
O	O	353	361	response	response	B-NP	NN	O	26	PMOD	O
O	O	362	364	to	to	B-PP	TO	O	27	NMOD	O
O	O	365	380	glucocorticoids	glucocorticoid	B-NP	NNS	O	28	PMOD	O
O	O	380	381	.	.	O	.	O	18	P	O

O	O	382	385	The	The	B-NP	DT	O	2	NMOD	O
O	O	386	390	role	role	I-NP	NN	O	12	SUB	O
O	O	391	393	of	of	B-PP	IN	O	2	NMOD	O
T1	B-Entity	394	403	chromatin	chromatin	B-NP	NN	B-DNA	5	NMOD	B-DNA
O	O	404	415	degradation	degradation	I-NP	NN	O	7	NMOD	O
O	O	416	419	and	and	O	CC	O	7	NMOD	O
O	O	420	433	endonucleases	endonucleas	B-NP	NNS	B-protein	3	PMOD	B-protein
O	O	434	436	in	in	B-PP	IN	O	2	NMOD	O
O	O	437	440	the	the	B-NP	DT	O	11	NMOD	O
O	O	441	450	apoptotic	apoptotic	I-NP	JJ	O	11	NMOD	O
O	O	451	458	process	process	I-NP	NN	O	8	PMOD	O
O	O	459	462	has	have	B-VP	VBZ	O	0	ROOT	O
O	O	463	467	been	be	I-VP	VBN	O	12	VC	O
O	O	468	475	closely	closely	I-VP	RB	O	13	VMOD	O
O	O	476	483	studied	study	I-VP	VBN	O	13	VC	O
O	O	483	484	,	,	O	,	O	12	P	O
O	O	485	487	as	as	B-CONJP	RB	O	21	NMOD	O
O	O	488	492	well	well	I-CONJP	RB	O	17	DEP	O
O	O	493	495	as	as	I-CONJP	IN	O	17	DEP	O
O	O	496	499	the	the	B-NP	DT	O	21	NMOD	O
O	O	500	511	involvement	involvement	I-NP	NN	O	12	VMOD	O
O	O	512	514	of	of	B-PP	IN	O	21	NMOD	O
O	O	515	522	several	several	B-NP	JJ	O	22	PMOD	O
T2	B-Entity	523	532	oncogenes	oncogene	I-NP	NNS	B-DNA	23	NMOD	B-DNA
O	O	533	535	in	in	B-PP	IN	O	21	NMOD	O
O	O	536	550	glucocorticoid	glucocorticoid	B-NP	NN	O	30	NMOD	O
O	O	550	551	-	-	B-NP	HYPH	O	30	NMOD	O
O	O	551	558	induced	induce	I-NP	VBN	O	30	NMOD	O
O	O	559	563	cell	cell	I-NP	NN	O	30	NMOD	O
O	O	564	569	lysis	lysis	I-NP	NN	O	25	PMOD	O
O	O	569	570	.	.	O	.	O	12	P	O

O	O	571	573	In	In	B-PP	IN	O	18	VMOD	O
O	O	574	582	addition	addition	B-NP	NN	O	1	PMOD	O
O	O	582	583	,	,	O	,	O	18	P	O
O	O	584	587	the	the	B-NP	DT	O	6	NMOD	O
O	O	588	596	clinical	clinical	I-NP	JJ	O	6	NMOD	O
O	O	597	607	importance	importance	I-NP	NN	O	18	SUB	O
O	O	608	610	of	of	B-PP	IN	O	6	NMOD	O
O	O	611	625	glucocorticoid	glucocorticoid	B-NP	NN	O	11	NMOD	O
O	O	625	626	-	-	B-NP	HYPH	O	11	NMOD	O
O	O	626	633	induced	induce	I-NP	VBN	O	11	NMOD	O
O	O	634	643	apoptosis	apoptosis	I-NP	NN	O	7	PMOD	O
O	O	644	646	in	in	B-PP	IN	O	11	NMOD	O
O	O	647	650	the	the	B-NP	DT	O	14	NMOD	O
O	O	651	660	treatment	treatment	I-NP	NN	O	12	PMOD	O
O	O	661	663	of	of	B-PP	IN	O	14	NMOD	O
O	O	664	672	lymphoid	lymphoid	B-NP	JJ	O	17	NMOD	O
O	O	673	682	neoplasms	neoplasm	I-NP	NNS	O	15	PMOD	O
O	O	683	686	has	have	B-VP	VBZ	O	0	ROOT	O
O	O	687	695	recently	recently	I-VP	RB	O	18	VMOD	O
O	O	696	704	received	receive	I-VP	VBN	O	18	VC	O
O	O	705	714	increased	increase	B-NP	VBN	O	22	NMOD	O
O	O	715	724	attention	attention	I-NP	NN	O	20	OBJ	O
O	O	724	725	.	.	O	.	O	18	P	O
